Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(−)-lansoprazole enantiomers and related impurities
- 15 August 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 50 (1) , 9-14
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Two‐dimensional chromatography method applied to the enantiomeric determination of lansoprazole in human plasma by direct sample injectionChirality, 2009
- Enantioseparation of kavain on Chiralpak IA under normal‐phase, polar organic and reversed‐phase conditionsJournal of Separation Science, 2008
- Semipreparative chiral supercritical fluid chromatography in the fractionation of lansoprazole and two related antiulcer drugs enantiomersJournal of Separation Science, 2008
- Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?World Journal of Gastroenterology, 2008
- Single-Isomer DrugsClinical Pharmacokinetics, 2004
- Determinaton of sildenafil citrate and related substances in the commercial products and tablet dosage form using HPLCJournal of Pharmaceutical and Biomedical Analysis, 2001
- Pharmacokinetic Differences between Lansoprazole Enantiomers and Contribution of Cytochrome P450 Isoforms to Enantioselective Metabolism of Lansoprazole in Dogs.Biological and Pharmaceutical Bulletin, 2001
- RabeprazoleDrugs, 1998
- Proton Pump InhibitorsDrugs, 1998
- The Pharmacology of the Gastric Acid Pump: The H+,K+ ATPaseAnnual Review of Pharmacology and Toxicology, 1995